Novo Holdings
Overview
Novo Holdings is a Danish holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as the controlling shareholder for Novo Nordisk A/S and Novonesis A/S while investing globally in life science companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Expedition Therapeutics | Aug 2026 | Series B | Co-investor |
| Claris Bio | Jul 2026 | Series B | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| The Protein Brewery | Jul 2026 | Series B Extension | Co-investor |
| cAMPfield Therapeutics | Jun 2026 | Series A | Co-investor |
Key People
Amit Kakar
Managing Partner, Head of Novo Holdings Asia
Anders Spohr
Managing Partner, Head of Planetary Health Investments
Robert Ghenchev
Managing Partner, Growth Investments
Scott Beardsley
Managing Partner, Venture Investments, Novo Holding US
Abhijeet Lele
Senior Partner and Head of US Principal Investments
Cynthia Kueppers
Senior Partner
Daniel Mahony
Senior Partner, Novo Growth Investments
Johan Hueffer
Head of Growth Investments (interim), Chair, Growth Investments Investment Committee, Member, Planetary Health Investments Investment Committee, Chair Novo Advisory Group, Senior Partner, Principal Investments
Jørgen Søberg Petersen
Senior Partner
Ken Harrison
Senior Partner
Søren Thinggaard Hansen
Senior Partner & Head of Private Equity
Aaron Nelson
Partner
Aleks Engel
Partner, Novo Holdings (Planetary Health Investments)
Andreas Nahne Nickelsen
Partner, Real Estate
Camilla Petrycer Hansen
Partner, Novo Holdings and REPAIR Impact Fund
Charles Patten
Partner, Private Equity
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
